Task: Answer the multiple choice question.
Query: Which drug exhibits a -13.121% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
(a) CCCC1Cc2[nH]c(=O)c(C#N)cc2CO1
(b) CCC(C)NC(=O)CSC1=Nc2ccccc2C2=NC(c3ccccc3)C(=O)N12
(c) Cc1ccc(NC(=O)CN2C(=O)NC(C)(C3CC3)C2=O)c([N+](=O)[O-])c1
(d) Cc1ccc(CNC(=O)C(NS(=O)(=O)c2cccs2)C(C)C)cc1
Answer: c. Cc1ccc(NC(=O)CN2C(=O)NC(C)(C3CC3)C2=O)c([N+](=O)[O-])c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(NC(=O)CN2C(=O)NC(C)(C3CC3)C2=O)c([N+](=O)[O-])c1
Cc1ccc(NC(=O)CN2C(=O)NC(C)(C3CC3)C2=O)c([N+](=O)[O-])c1
2-(4-cyclopropyl-4-methyl-2,5-dioxoimidazolidin-1-yl)-N-(4-methyl-2-nitrophenyl)acetamide